Details of the Drug Reposition

General Information of This Drug (ID: DMHSLVJ)

Drug Name	Anti-CD19 CAR transduced T cells DMHSLVJ
Drug Type	CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

3 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Lymphoma	DISN6V4S	2A80-2A86	Phase 1/2	[1]
Chronic lymphocytic leukaemia	DISEXWC3	2A82.0	Phase 1/2	[1]
Acute lymphocytic leukaemia	DISPX75S	2B33.3	Phase 1/2	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03191773) A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies